NRx Pharmaceuticals, Inc.

NasdaqCM:NRXP Stock Report

Market Cap: US$40.9m

NRx Pharmaceuticals, Inc. Company Information

NRx Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: NRx Pharmaceuticals, Inc.
  • Ticker: NRXP
  • Exchange: NasdaqCM
  • Founded: 2015
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$40.864m
  • Shares Outstanding: 9.50m
  • Website: https://www.nrxpharma.com

Location

  • NRx Pharmaceuticals, Inc.
  • 1201 Orange Street
  • Suite 600
  • Wilmington
  • Delaware
  • 19801
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NRXPNasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDDec 2017
B1QDB (Deutsche Boerse AG)YesNew Common StockDEEURDec 2017
B1QMUN (Boerse Muenchen)YesNew Common StockDEEURDec 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/17 00:00
End of Day Share Price 2024/04/17 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.